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Abstract 
GABA-containing fibers have been observed in the rat superior cervical ganglion (SCG) and, 
to a lesser extent, in the stellate ganglion (STG). The aim of present study is to clarify the source 
of these fibers. No cell body showed mRNAs for glutamic acid decarboxylases (GADs) or 
immunoreactivity for GAD of 67 kDa (GAD67) in the cervical sympathetic chain.  Thus, 
GABA-containing fibers in the ganglia are suggested to be of extraganglionic origin. Since 
GAD67-immunoreactive fibers were found not in the dorsal roots or ganglia, but in the ventral 
roots, GABA-containing fibers in the sympathetic ganglia were considered to originate from the 
spinal cord. Furthermore, almost all GAD67-immunoreactive fibers in the sympathetic ganglia 
showed immunoreactivity for vesicular acetylcholine transporter, suggesting that GABA was 
utilized by some cholinergic preganglionic neurons. This was confirmed by the following results: 1) 
after injection of Sindbis/palGFP virus into the intermediolateral nucleus, some anterogradely 
labeled fibers in the SCG were immunopositive for GAD67, and 2) after injection of fluorogold into 
the SCG, some retrogradely labeled neurons in the thoracic spinal cord were positive for GAD67 
mRNA. Finally, when the ventral roots of the eighth cervical to the fourth thoracic segments were 
cut, almost all GAD67- and GABA-immunoreactive fibers disappeared from the ipsilateral SCG 
and STG, suggesting that the vast majority of GABA-containing fibers in those ganglia were of 
spinal origin. Thus, the present findings strongly indicate that some sympathetic preganglionic 
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neurons are not only cholinergic, but also GABAegic.
Keywords: nerve transection, co-localization, anterograde tracing, retrograde tracing, 
immunohistochemistry, in situ hybridization
Abbreviations: SPN, sympathetic preganglionic neuron; VAchT, vesicular acetylcholine transporter; 
IML, nucleus intermediolateralis; SCG, superior cervical ganglion; STG, stellate ganglion; DRG, 
dorsal root ganglion; VR, ventral root; DR, dorsal root; LF, lateral funiculus; PF, posterior 
funiculus; cc, central canal; DH, dorsal horn; FG, fluorogold; GAD, glutamic acid decarboxylase; 
GFP, enhanced green fluorescent protein; SIF, small intensely fluorescent; PB, 0.1M phosphate 
buffer (pH 7.4); PBS, 0.05M phosphate-buffered saline (pH 7.4); PBS-X, PBS containing 0.3% 
Triton X-100; PBS-XD, PBS containing 0.3% Triton X-100, 1% normal donkey serum; RT, room 
temperature; NLS, N-lauroylsarcosine; DAB, diaminobenzidine; FITC, fluorescein isothiocyanate; 
TSA, tyramide signal amplification; GST, glutathione-S-transferase.
Page 3 of 49
John Wiley & Sons
Journal of Comparative Neurology
For Peer Review
1.  Introduction
   Sympathetic postganglionic neurons receive many kinds of chemical inputs in the sympathetic 
ganglia.  The chemical inputs are classified into two major groups: 1) cholinergic excitatory or 
facilitatory afferents, and 2) inhibitory or suppressive afferents (e.g. GABA, enkephalin, and 
dopamine). These inputs are derived not only from sympathetic preganglionic neurons (SPNs) in 
the spinal cord, but also from primary sensory neurons in the dorsal root ganglia (DRGs), enteric 
neurons in the gastro-intestinal tract, and small intensely fluorescent (SIF) cells within the
sympathetic ganglia.  It is very important for understanding the function of sympathetic ganglia 
(i.e. neural computation, integration of inputs, etc) to investigate both the chemical characteristics 
and origin of afferent fibers projecting to the ganglia. 
The superior cervical ganglion (SCG) is located in the most rostral part of the sympathetic 
chain, and is the only sympathetic ganglion which projects to various organs in the head and face 
(e.g. pineal body, iris, salivary glands, cochlea, lacrimal gland, etc).  Because these organs have 
quite unique roles in autonomic functions, the neural circuit of the ganglia is likely to be also 
specialized. For understanding the function of the SCG, it is very important to identify specific 
features (e.g. chemical properties of preganglionic fibers and postganglionic neurons, physiological 
properties, morphology of postganglionic neurons, etc) in the ganglion.
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The usage of GABA, an inhibitory neurotransmitter in the central nervous system, in the 
sympathetic nervous system, including the SCG (Amenta et al., 1992; Dobo et al., 1990, 1993; 
Guillermo et al., 1994; Liu and Burt, 1999; Wolff et al., 1989, 1993a, 1993b) has been reported.  
Interestingly, GABA-immunopositive fibers are distributed in the rostral sympathetic trunk with a 
rostrally deviated gradient, and the number of GABA-immunopositive fibers reaches a maximum 
in the cervical sympathetic trunk (Wolff et al., 1993a).  These GABA-containing fibers make 
numerous axon baskets with varicosities in the SCG (Wolff et al., 1989).  These observations 
imply that GABA has an unique role in SCG-specific neural functions. 
Wolff and colleagues argued that, in the cervical sympathetic chain, which is composed of 
the SCG, STG, and cervical sympathetic trunk, SIF-like cells extended their axons and projected to 
the SCG (Dobo et al., 1990; Wolff et al., 1993a). We recently reported that, in the mouse SCG,
almost all GABA-containing varicosities were immunopositive for vesicular acetylcholine 
transporter (VAchT), suggesting a spinal origin of the GABA-containing cholinergic fibers (Ito et al. 
2005). The DRG neurons may be another candidate for the origin of GABA-containing fibers 
because a few axons of the DRG fibers pass through the cervical sympathetic trunk (Murata et al., 
1982), and GABA-immunopositive DRG neurons have been reported (Szabat et al., 1992). 
Therefore, there are three candidates for the source (SIF-like cells, SPNs, and the DRG neurons) of 
GABA-containing fibers in the SCG.
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To reveal the source of GABA-containing fibers in the SCG, we first investigated the 
distribution of mRNAs for GADs of 65 and 67kDa (GAD65 and GAD67). Second, we studied 
possible sources by double immunohistochemistry, nerve transection, and anterograde and 
retrograde tracer labelings. 
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2.  Materials and methods
2. 1.  Animals
   Twenty-two adult male Sprague-Dawley rats (body weight: 200-250g, Japan SLC, Shizuoka 
Japan) were used in this study.  All animals were maintained and treated according to the 
Guidelines for Animal Experiments of the University of Fukui and Kyoto University.  All efforts 
were made to minimize animal suffering and the number of animals used. 
2. 2.  Surgery
2. 2. 1.  Anterograde tracing
   Three rats were deeply anesthetized with chloral hydrate (400 mg/kg body weight, i.p.) and 
fixed in a stereotaxic apparatus in the prone position.  A laminectomy of vertebra T1 was carried 
out to expose the dorsal surface of the spinal cord.  About 0.6 µl of viral solution containing 
Sindbis/palGFP virus (Furuta et al., 2001) was injected by pressure (0.7 kg/cm2) of N2 gas through 
a glass micropipette.  The injection coordinates were at 0.5 mm right of the posterior median 
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sulcus and 0.6 mm below the dorsal surface of the spinal cord.  Overflowing liquid was carefully 
absorbed with kimwipe (Crecia, Tokyo, Japan).  After the surgery, animals were allowed to survive 
for 18 hours.  Throughout the survival period, a large amount of palmitoylated GFP was produced 
in the infected neurons, and outlined the complete neuronal morphology (i.e. Golgi-like staining).  
Within this survival period, the death of infected neurons was minimal (Furuta et al., 2001). 
2. 2. 2.  Retrograde tracing
  Three rats were deeply anesthetized with chloral hydrate (400 mg/kg body weight, i.p.), 
supinely fixed in a stereotaxic apparatus, and injected with 1 µl of 4 % (w/v) FG in the right SCG 
by pressure (0.5 kg/cm2) of N2 gas through a glass micropipette.  After the injection, animals were 
allowed to survive for 2 days. 
2. 2. 3.  Nerve transection
Seven rats were deeply anesthetized with chloral hydrate (400 mg/kg body weight, i.p.).  The 
inferior articular processes of vertebrae C8-T4 were removed to expose the dorsal surface of the 
right DRGs, and dorsal and ventral roots (DRs and VRs) of C8-T4 were cut with a spring scissors.  
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After the surgery, animals were allowed to survive for 4 days.  We dissected these animals after the 
perfusion and confirmed that the transection was complete. 
2. 3.  Immunohistochemistry
2. 3. 1.  Antibodies
    In this study, we used a mouse monoclonal antibody for GAD67 (MAB5406, Chemicon, 
Temecula, CA, USA), a goat polyclonal antibody for VAchT (AB1578, Chemicon), and rabbit 
polyclonal antibodies for FG (AB153, Chemicon), GFP (Tamamaki et al., 2000), and GABA (A2052, 
Sigma-Aldrich, St Louis, MO, USA) as primary antibodies (Table 1). 
Although the specificity of the mouse monoclonal antibody for GAD67 had already been 
checked by immunoblotting (Fong et al., 2005), an absorption test had not been conducted.  In the 
present study, we carried out an absorption test with the glutathione-S-transferase (GST)-GAD67 
fusion protein as an antigen.  First, the entire coding sequence of the rat GAD67 cDNA (GenBank 
accession number M76177) was subcloned into the SmaI site of pGEX-4T2 (GE healthcare 
bioscience, Fairfield, CT).  Then, expression of GST-GAD67 was induced in E. coli by adding 
isopropyl-l-thio-beta-D-galactopyranoside to the medium.  The fusion protein was extracted from 
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the medium with CelLytic B (Sigma), and purified on a GST-column (GE Healthcare Bio-Sciences
Piscataway, NJ, USA).  In immunoblot, the fusion protein was recognized by the anti-GAD67 
antibody, giving a single band around 100 kDa.  This molecular weight was in good agreement 
with the estimated molecular weight of GST-GAD67 (approximately 97 kDa).
We preincubated the anti-GAD67 antibody (1:3000) with this fusion protein (180 µg/ml) diluted in 
0.3% (w/v) Triton X-100, 1% (v/v) normal donkey serum in 0.05M phosphate-buffered saline
(PBS-XD; pH 7.4) for 1 hour at room temperature (RT).  The sections immunostained with the 
anti-GAD67 antibody preabsorbed with GST-GAD67 showed no immunopositive signal in the SCG 
(Fig. 1e2), STG (Fig. 1f2), or brain (Fig. 1h2).  Furthermore, GAD67 immunoreactivity in the brain 
(Fig. 1h1) was very similar to that in a previous study (Mugnaini and Oertel, 1985), and the 
distribution of GAD67-immunopositive cell bodies was well consistent with that of 
GAD67-expressing cell bodies (Fig. 2f1).   These observations strongly indicated that the antibody 
was specific for GAD67. 
To check the specificity of the goat polyclonal antibody for VAchT, we again performed an
absorption test.  We preincubated the anti-VAchT antibody (1:4000) with VAchT control peptide 
(1:50; AG260; Chemicon) diluted in PBS-XD for 1 hour at RT, and confirmed the absence of 
immunostaining (not shown).  Likewise, to check the specificity of the rabbit polyclonal antibody 
for GABA, we preincubated the antibody (1:10000) with GABA (0.5M) diluted in PBS-XD for 1 
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hour at RT.  The sections of the SCG incubated with the anti-GABA antibody preabsorbed with 
GABA showed no immunoreactivity in any region examined (Fig. 1d). The specificity of 
antibodies for GFP and FG was confirmed by a lack of stainings in the sections of animals not 
injected with Sindbis/palGFP or FG.
2. 3. 2.  Tissue preparation
  Animals were deeply anesthetized with an overdose of chloral hydrate (800 mg/kg body weight, 
i.p.) and perfused transcardially with saline, followed by a fixative containing 4% (w/v) 
paraformaldehyde diluted with 0.1M phosphate buffer (PB; pH 7.4).  In the immunohistochemistry 
for GABA, we instead used 4% (w/v) paraformaldehyde, 0.05% (v/v) glutaraldehyde diluted with 
0.1M PB as a fixative.  The SCGs and STGs of both sides, the spinal cord, DRs, VRs, and DRGs 
from C8 to T4 levels were dissected out and postfixed with the same fixative for 2 hours at RT.
The specimens were immersed in 30% (w/v) sucrose in 0.1M PB overnight at 4°C.  After 
embedding in OCT compound (Pelco, Redding, CA, USA), frozen sections of the spinal cord were 
made transversely at a thickness of 30 µm by cryostat, and collected in 0.05M phosphate-buffered
saline (PBS; pH 7.4). Sections of the DRs, VRs, DRG, STG, and SCG were made pallarel to the 
longitudinal axis at a thickness of 14 µm by cryostat, mounted on APS-coated glass slides, and 
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air-dried.  Sections for the immunoperoxidase reaction were immersed in PBS containing 0.3% 
(v/v) H2O2  for 15 minutes to remove the endogenous peroxidase reactivity.
2. 3. 3.  Immunohistochemistry for confocal microscopy
    Sections were incubated overnight with goat anti-VAchT (1:1000), rabbit anti-FG (1:2000), 
rabbit anti-GFP (1:100), mouse anti-GAD67 (1:1000), or rabbit anti-GABA (1:3000) diluted in 
PBS-XD, followed by fluorescein isothiocyanate (FITC) donkey anti-goat IgG (1:200; Rockland 
Immunochemicals, Gilbertsville, PA, USA) to visualize VAchT-immunoreactivity, Cy3 donkey 
anti-rabbit IgG (1:400; Chemicon) for FG, Cy3 donkey anti-mouse IgG (1:400; Rockland) for 
GAD67, and FITC donkey anti-rabbit IgG (1:200; Chemicon) for GFP and GABA diluted in 
PBS-XD.  As GAD-immunoreactivity in neuronal somata increases when the sections are 
incubated without Triton X-100 (Mugnaini and Oertel, 1985), we incubated some sections without 
Triton X-100 to enhance the GAD67-immunoreactivity of neuronal somata.  To amplify 
immunopositive signals, some sections incubated with anti-GAD67 or anti-GABA were then 
incubated with HRP-conjugated donkey antibodies for mouse or rabbit IgG (1:100; Chemicon), 
respectively, and reacted with a tyramide signal amplification (TSA) fluorescein system (Perkin 
Elmer, Wellesley, MA, USA).  Then, sections were mounted on glass slides with 
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VECTORSHIELD (Vector Laboratories, Burlingame, CA, USA). 
2. 3. 4.  Immunohistochemistry for bright field microscopy
    Some sections were pre-incubated with an Avidin/Biotin Blocking Kit (Vector) to block 
endogenous biotin.  The sections were then incubated with goat anti-VAchT (1:4000), rabbit 
anti-GFP (1:400), mouse anti-GAD67 (1:3000), and rabbit anti-GABA (1:3000) diluted in PBS-XD, 
followed by biotinylated donkey secondary antibodies (biotinylated anti-mouse IgG, biotinylated 
anti-rabbit IgG or biotinylated anti-goat IgG; 1:200; Rockland) diluted in PBS-XD, and further 
incubated with avidin-biotinylated peroxidase complex (1:50; ABC-Elite, Vector) in PBS containing 
0.3% (w/v) Triton X-100 (PBS-X).  In some sections of the SCG, we omitted primary antibodies, 
and confirmed an absence of staining.  To reveal GAD67-immunoreactivity in the neuronal 
somata, we processed some sections without Triton X-100.  These sections were used for a
diaminobenzidine (DAB) or Nickel-DAB reaction.   The sections were dehydrated with graded 
alcohols, cleared with xylene, and mounted on glass slides with Entellan (Merck, Germany).  
2. 4.  In situ hybridization histochemistry
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2. 4. 1.  Single in situ hybridization
   Complementary DNA fragments corresponding to a region of the GAD67 (nucleotides 227-845, 
GenBank accession number BC_027059) and GAD65 (69-693, D42051) cDNAs were cloned into 
pBluescript II SK (+) (Stratagene, La Jolla, CA, USA).   Using this plasmid as a template, sense 
and antisense single-strand RNA probes were synthesized with a digoxigenin labeling kit (Roche 
Diagnostics, Mannheim, Germany).  The procedure for non-radioactive in situ hybridization was
described elsewhere (Liang et al., 2000).  Briefly, three rats were anesthetized with an overdose of 
chloral hydrate (800 mg/kg body weight, i.p.) and perfused transcardially with saline, followed by 
4% paraformaldehyde diluted in PB.  The whole brain, spinal cord from C8 to T5, right DRGs 
from C8 to T5, right SCG, and right STG with cervical sympathetic trunk were dissected out and 
postfixed with the same fixative for 4 hours at RT.  The specimens were immersed in 
DEPC-treated cryoprotectant (0.1M PB containing 30% (w/v) sucrose) overnight at 4°C and cut 
parallel to the longitudinal axis at a thickness of 45 µm by cryostat.  The free-floating sections 
were washed in 0.1M PB for 5 minutes twice, immersed in 0.1M PB containing 0.3% (w/v) Triton 
X-100, and washed in 0.1M PB.  The sections were treated with acetylation solution (0.003% (v/v) 
acetic acid anhydrate/ 1.3% (v/v) triethanolamine/ 6.5% (w/v) HCl in DEPC-treated water) for 10 
minutes at RT.  After two washes in PB, they were incubated in a prehybridization solution
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containing 50% (v/v) formamide (Nacalai Tesque, Kyoto, Japan)/ 5 x SSC/ 2% (w/v) blocking 
reagents (Roche)/ 0.1% (w/v) N-lauroylsarcosine (NLS)/ 0.1% (w/v) SDS for 1 hour at 60°C.   
The sections were hybridized with 1 µg/ml digoxigenin-labeled sense or antisense RNA probe for 
GAD67 and GAD65 in the prehybridization solution for 20 hours at 60°C and 72°C, respectively.   
After two washes in 2xSSC/ 50% (v/v) formamide/ 0.1% (w/v) NLS for 20 minutes at 60°C or 
72°C, the sections were incubated with 20 µg/ml RNase A (Nacalai) for 30 minutes at 37°C, and 
washed in 2xSSC/ 0.1% (w/v) NLS for 20 minutes twice at 37°C, followed by 0.2xSSC/ 0.1% (w/v) 
NLS for 20 minutes twice at 37°C. The sections were blocked with 1% (w/v) blocking reagent
(Roche) diluted in Tris-HCl (pH7.5), 0.15M NaCl (TS7.5) for 1 hour at RT, and incubated with an 
alkaline phosphatase-conjugated anti-digoxigenin antibody Fab fragment (1:2000; Roche) in 1% 
(w/v) blocking reagent (Roche) diluted in TS7.5 at RT overnight.  The bound phosphatase was 
visualized by a reaction with NBT/BCIP for 4 hours at 37°C in Tris-HCl (pH9.5), 0.15M NaCl.  
Sections were mounted on glass slides, dehydrated, cleared with xylene, and coverslipped. 
2. 4. 2.  In situ hybridization combined with immunohistochemistry
Three rats which received FG in the right SCG as described above were anesthetized with an 
overdose of chloral hydrate (800 mg/kg body weight, i.p.) and perfused transcardially with saline, 
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followed by 4% paraformaldehyde diluted with 0.1M phosphate buffer.  The spinal cord from C8 
to T5 was dissected out and postfixed with the same fixative for 4 hours at RT.  The specimens 
were immersed in DEPC-treated cryoprotectant (PB containing 30% (w/v) sucrose) overnight at 
4°C and cut parallel to the longitudinal axis at a thickness of 45 µm by cryostat. Every second 
section was processed for a combination of immunoperoxidase and alkaline phosphatase reactions, 
and the rest were processed for a combination of immunofluorescent and fluorescent in situ 
hybridization histochemistries.
For double labeling bright field microscopy, the sections were washed in DEPC-treated PBS 
twice, and incubated with rabbit anti-FG (1:3000) diluted in 1% (w/v) blocking reagent (Roche) in 
DEPC-treated PBS-X at RT overnight.  After three washes in DEPC-treated PBS, the sections 
were incubated for 1 hour in 1% (w/v) blocking reagent (Roche) in DEPC-treated PBS-X with 
biotinylated anti-rabbit IgG donkey antibody (1:200; Rockland), and further incubated with 
ABC-Elite diluted in DEPC-treated PBS-X.  FG immunoreactivity was revealed as the DAB 
reaction product.  Then these sections were processed with bright field in situ hybridization
histochemistry as described above. 
 For double fluorescent labeling, sections were washed in DEPC-treated PBS twice, and 
incubated with rabbit anti-FG (1:500) diluted in 1% (w/v) blocking reagent (Roche) in 
DEPC-treated PBS-X at RT overnight.  After three washes in DEPC-treated PBS, sections were 
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incubated for 1 hour in 1% (w/v) blocking reagent (Roche) in DEPC-treated PBS-X with 
FITC-labeled anti-rabbit IgG donkey antibody (1:200; Chemicon), and fixed with 4% (w/v) 
paraformaldehyde in 0.1M PB for 15 minutes.  These sections were processed with in situ 
hybridization.  To visualize alkaline phosphatase by fluorescent microscopy, sections were 
developed with 0.005% (w/v) FastRed (Roche), 1% (v/v) HNPP (Roche) diluted in Tris-HCl 
(pH8.0), 0.15M NaCl for 2 hours at RT.  The sections were mounted on glass slides with 
Permafluor (Beckman Coulter, Fullerton, CA). 
2. 5.  Micrographs
   All micrographs were collected digitally.  Bright field micrographs were taken by CCD-camera 
(HC2500, Fujifilm, Japan).  Fluorescent micrographs were taken by confocal laser scanning 
microscope (TCS-SP2-AOBS, Leica Microsystems, Germany).  FITC was excited with a 488-nm 
laser beam and observed through a 510-560 nm AOBS emission filter.  FastRed and Cy3 were 
excited with a 543-nm laser beam, and observed through  570 nm AOBS emission filters.  We 
used a x63 oil-immersive objective (N.A. = 1.4; Leica) for the determination of axonal 
co-localization in double immunostained sections.  Digital images were stored in TIFF format and 
edited for optimal contrast and brightness in Photoshop CS2 (Adobe Systems, San Jose, CA, USA) 
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for both bright field and confocal micrographs. 
2.6. Counting procedures
  When we counted the number of varicosities, we used a laser confocal microscope, observed 
the specimen with a x63 oil-immersive lens through a x4 zoom, and took digital images with a 
resolution of 512x512.  Under the conditions, pixel size (0.12 µm) was smaller than the resolution 
of the lens (approximately 200 nm). We counted the number of varicosities from randomly chosen 
areas of 3 ganglia. When we counted the number of axon baskets, we only chose cells which were 
completely surrounded by varicose fibers (inset of Fig. 1e1). Concerning cell counting, only those
cells whose nuclei were observed were chosen.  Because we chose every second section for 
counting FG-positive cells, and the thickness of these sections (45 µm) was much greater than the
mean diameter of FG-positive neuronal nuclei (13.7 ± 3.0 µm; mean ± S.D., obtained from 30 
neurons of 3 animals), the occurrence of double counting error should have been avoided.
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3.  Results
3. 1.  GABA and GAD67 immunoreactivities in the SCG and STG 
In the SCG and STG, many GABA-immunopositive varicose fibers were observed, which
often made basket-like structures (Fig. 1a).  These basket-like structures were fewer in the STG 
(not shown) than in the SCG. As reported previously (Dobo et al., 1990, Wolff et al., 1993a), a 
few SIF-like cells showed GABA immunoreactivity (arrows in Fig. 1b, c).  Most of them had 
GABA-immunopositive processes, and appeared to be the type I cells described by Dobo et al.
(1990). GABA-immunopositive SIF-like cells were often in close proximity to 
GABA-immunopositive varicosities and fibers (arrowheads in Fig. 1b, c). 
    In the SCG, almost all GAD67-immunopositive structures were varicose fibers which 
frequently made basket-like structures, as observed with GABA immunostaining (Fig. 1e1). We 
counted the number of neurons which were surrounded by GAD67-positive varicose fibers (inset of 
Fig. 1e1).  One SCG contained 387.7 ± 58.4 neurons (mean ± S.D.; n=7) surrounded densely by 
GAD67-immunopositive axon baskets.  In the STG, only a few GAD67-positive axon baskets 
were observed (Fig. 1f1), and 35.3 ± 26.4 neurons (mean ± S.D.; n=4) were surrounded by 
GAD67-immunopositive baskets. In contrast to the GABA immunoreactivity, no 
GAD67-immunopositive cell body was found in the ganglia (Fig. 1e1, f1, g).  Even when sections 
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were incubated in the primary antibody solution without Triton X-100, and processed with the TSA 
method to enhance GAD67 immunoreactivity in neuronal somata, no immunoreactive cell body
was observed (Fig. 1g). These findings imply that, although some SIF-like cells contain GABA, 
they do not produce enough GAD67 to be detected in their cell bodies. 
3. 2.  GAD expression in the SCG and STG
    Since SIF-like cells showed GABA immunoreactivity, we examined whether these small cells 
express GAD mRNA by in situ hybridization histochemistry, but detected no GAD67 or GAD65
mRNA signal in the SCG, STG (Fig. 2a-d), or cervical sympathetic trunk (not shown). With the 
same antisense probes and histochemistry, strong signals for GAD65 (Fig. 2e1) and GAD67 (Fig. 
2f1) mRNAs were observed in many brain regions as reported previously (Esclapez et al., 1993).
These results indicate that the paravertebral ganglionic cells express little, if any, mRNA for the
GADs. 
 
3. 3.  GABAergic neuronal somata in the thoracic spinal cord and GABAergic fibers in the ventral 
roots. 
In the gray matter of the thoracic spinal cord, including the intermediolateral nucleus (IML), 
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many neurons expressed mRNAs for GAD65 and GAD67 (Fig. 3a1, b1). However, no mRNA
signal for GAD65 or GAD67 was observed in the DRGs (Fig. 3c, d), indicating that no DRG cell 
has synthetic mechanisms for GABA. Moreover, although the presence of 
GABA-immunopositive DRG neurons was reported previously (Szabat et al., 1992), we did not 
detect any GABA- (Fig. 3e) or GAD67-immunopositive structures (Fig. 3h) in the DRGs.  Nor 
were observed GABA- or GAD67-immunopositive fibers in the DRs of the proximal or distal side
of the DRGs (Fig. 3f, i). In contrast, many GABA- and GAD67-immunopositive fibers were 
found in the VRs (Fig. 3g, j), suggesting that some GABAergic efferents ran from the spinal cord to 
the periphery.
3. 4.  Origin of GABAergic fibers in the SCG and STG
The presence of GABA- and GAD67-immunopositive fibers in the VRs implies that 
GABAergic fibers in the SCG originate in the spinal cord.  Because all spinal cord neurons which 
send axons to the periphery are known to be cholinergic, GAD67-immunopositive fibers in the SCG 
and STG were expected to display immunoreactivity for VAchT. Actually, almost all 
GAD67-immunopositive varicosities showed immunoreactivity for VAchT in the ganglia (97.1%; 
268/276 randomly chosen GAD67-immunopositive varicosities; n=3 ; Fig. 4a-c’’).
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    In an attempt to confirm the spinal origin of GAD67-immunopositive fibers in the SCG and 
STG, GAD67 immunoreactivity was studied in the anterogradely labeled preganglionic fibers. 
After a small injection of Sindbis/palGFP virus into the lateral horn of the T1 segment, many
neurons were infected with the virus (Fig. 4d), and some of them were located in the IML (box in 
Fig. 4d; Fig. 4e).   Some GFP-labeled axons were observed in the ipsilateral STG and SCG, and 
had extensive varicose branches and basket-like structures (Fig. 4f).  In all 3 cases injected with 
the virus, GAD67 immunoreactivity was observed in some GFP-positive varicose structures 
(arrowheads in Fig. 4g-g'').  
We next examined whether retrogradely labeled SPNs showed GAD67 mRNA signals or not. 
After the injection of FG into the SCG, many neurons in the IML of C8-T5 spinal segments and a 
few neurons around the central canal were retrogradely labeled, being well consistent with previous 
reports (Rando et al., 1981; Strack et al., 1988). With the combination of FG immunofluorescence 
and fluorescent in situ hybridization for GAD67, some retrogradely labeled neurons showed mRNA 
signals for GAD67 (arrow in Fig. 5a-a’’). To further clarify the distribution of GAD67-expressing 
SPNs, we performed combined staining with an immunoperoxidase reaction for FG and an alkaline 
phosphatase reaction for GAD67 mRNA (Fig. 5b-d) from every other section collected. In all, 540 
± 42 (mean ± S.D.; n=3) neurons showed FG immunoreactivity, and 15 ± 3 neurons (2.78 ± 0.5 %)
were positive for both FG and GAD67.  They were located mainly in the rostral part of the IML
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and, to a much lesser extent, in other parts of the IML and around the central canal (Fig. 5d-f). 
Actually, the number of these neurons was significantly larger in the most rostral part of the IML 
(bar 0-2.3mm in Fig. 5e) than any other part of the IML and around the central canal (Tukey’s 
multiple analysis, p<0.05).  GAD67-expressing SPNs tended to be located in the central and lateral 
part of the gray matter (Fig. 5f), although no significance was detected (ANOVA, p=0.073).
Although the morphological reconstruction was limited by insufficient labeling of FG, 
GAD67-expressing (A-6, B-4-18, C-10 in Fig. 5c) and non-expressing SPNs (A-N1, B-N1, 2, C-N1 
in Fig. 5c) displayed no obvious differences in the shape of cell bodies and proximal dendrites.
Thus, at least some GABA- and GAD67-immunopositive fibers in the SCG and STG were 
considered to be of spinal origin.  
3. 5.  The effect of VR transection.
The ventral roots of C8 to T4 were transected to examine whether or not the SCG and STG 
had other sources of GAD67-immunopositive fibers than the spinal cord. Almost all 
GAD67-immunopositive structures disappeared from the SCG and STG on the operated side (Fig. 
6a, c), whereas GAD67-immunopositive structures remained almost unchanged in the contralateral 
ganglia (Fig. 6b, d). Furthermore, when the sections were immunostained for GABA, not only 
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GABA-immunopositive fibers but also GABA-immunopositive SIF-like cells disappeared from the 
sympathetic ganglia of the operated side (Fig. 6e).  On the contralateral side, however, 
GABA-immunopositive structures, including varicose fibers (Fig. 6f) and SIF-like cells (inset in 
Fig. 6f), were observed as in the normal ganglia. These results indicate that almost all GABAergic 
fibers in the SCG come from the spinal cord through the ipsilateral VRs.
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4.  Discussion
In this study, we demonstrated that 1) GABAergic neurons were present in the IML, but not
in the sympathetic chain or DRGs, 2) GABAergic fibers were present in the VRs but not in the 
DRs, 3) almost all GAD67-positive varicosities showed immunoreactivity for VAchT in the 
sympathetic ganglia, 4) GAD67 was expressed in the terminals and somata of SPNs, and 5) 
GABAergic fibers in the sympathetic ganglia disappeared after the VR transection. These 
observations clearly indicate that almost all GABAergic fibers in the cervical sympathetic chain 
originate from SPNs. The fact that some SPNs express GAD67 implies that these neurons 
co-release both acetylcholine and GABA.
4. 1.  Technical consideration 
   Because there is a limitation to the sensitivity of in situ hybridization histochemistry, especially 
in the case of GAD65, the number of GAD-expressing cells might be underestimated.  Therefore, 
we cannot exclude the possibility that SIF cells and DRG neurons express a small amount of 
GAD65, but not GAD67. However, this is unlikely because GAD65 and GAD67 are known to be
expressed in the same neuron (Esclapez et al., 1993).  Even if SIF cells and DRG neurons contain 
GAD65, these cells seem to have less importance in the GABAergic fibers in the SCG, because 1) 
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GABAergic fibers were found in the VRs, but not in the DRs, 2) no GABAergic SIF-like cell was 
found in the VRs, and 3) GABAergic fibers disappeared after the transection of the ventral roots.
    Since the immunoperoxidase reaction product interfered with the alkaline phosphatase reaction, 
it is possible that the number of GAD67-expressing SPNs was underestimated in Figure 5b-f.  We 
estimated the number of GAD67-expressing SPNs projecting to the unilateral SCG at about 30
because we observed about 15 neurons in half of all serially collected sections.  Since a single 
preganglionic axon branches into 11-14 terminal baskets in the SCG (Asamoto et al., 1997), the 
number of GAD67-positive basket may be about 330-420, being in good agreement with our 
observation (387.7 ± 58.4 baskets within an SCG).  Thus, the underestimation, if any, may not 
greatly affect our conclusion.
4.2. GABA immunoreactivity in SIF-like cells and DRG neurons 
Wolff and colleagues emphasized the existence of GABAergic SIF-like cells in the cervical 
sympathetic chain (Dobo et al., 1990; Wolff et al., 1993a). Although we found 
GABA-immunopositive SIF-like cells in the SCG and STG (Fig. 1b, c), we did not observe SIF-like 
cells expressing GAD65 or GAD67.  Similarly, although GABA-immunopositive DRG neurons 
were reportedly detected using monoclonal antibody for GABA (Szabat et al., 1992), we did not 
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detect a mRNA signal for GAD65 or GAD67 in the DRG or GAD67 immunoreactivity in the DRs. 
Thus, neither DRG neurons nor SIF-like cells showed evidence of GABA production. It is 
suggested that GABA-immunopositive SIF-like cells do not produce GABA, but take up and 
accumulate GABA released from the GABAergic terminals.  Actually, the disappearance of 
GABA-immunopositive SIF-like cells after the transection of VRs is consistent with this 
suggestion. 
4. 3.  Unique properties of SPNs located in the most rostral part of the IML
  One of the most interesting results from this study is that most GABAergic SPNs are located in 
the most rostral part, about C8-T2, of the IML.  The rostral IML is known to have some unique 
properties: SPNs in this area receive strong orexin input (Llewellyn-Smith et al., 2003) and much 
less serotonin input than SPNs in more caudal segments (Jensen et al., 1995).  In addition, 
neurokinin-1 receptor-immunopositive SPNs are fewer in T1 and T2 than in the more caudal 
segments (Llewellyn-Smith et al., 1997).  These findings suggest that rostral SPNs are chemically 
coded, and may have a specific function. These characteristics of rostral SPNs, which mainly 
project to the SCG, are likely to be associated with the functions of head- and face-specific organs 
(e.g. the pineal body, iris, salivary glands, cochlea, lacrimal gland, etc).
Page 27 of 49
John Wiley & Sons
Journal of Comparative Neurology
For Peer Review
4. 4.  Functional considerations
    Wolff and colleagues proposed the "feed-forward inhibition" mechanism (Wolff et al., 1993a), 
in which SPNs excited SIF-like cells in the cervical sympathetic chain, and GABA-immunopositive 
SIF-like cells sent the axons to the SCG and inhibited the postganglionic neurons.  However, in the 
present study, we showed that 1) no signal for GAD mRNAs was detected in the cervical 
sympathetic chain, and 2) all GAD67-immunopositive varicosities were cholinergic and of spinal 
origin.  Thus, the "feed-forward inhibition" mechanism seems unlikely in the sympathetic ganglia. 
Because both acetylcholine receptors and GABAA receptors are expressed in the SCG (Amenta et 
al., 1992; Liu and Burt, 1999), the present findings imply the co-release of excitatory (i.e. 
acetylcholine with nicotinic receptor) and “inhibitory” (i.e. GABA with GABAA receptor) 
neurotransmitters from some preganglionic fibers in the SCG. Dobo and colleagues (1993) 
reported that GABA-immunopositive fibers mainly innervated NPY-negative large postganglionic 
neurons.  Since about half of all postganglionic neurons are NPY-positive vasoconstrictors
(Gibbins, 1995), it can be postulated that half of all GAD-positive baskets would encircle 
NPY-positive postganglionic neurons if GABAergic fibers randomly choose the postganglionic 
target.  However, only 10% of GAD-immunopositive baskets actually encircled NPY-positive 
postganglionic neurons (Ito et al., 2005), suggesting that GABAergic baskets do not prefer 
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NPY-positive vasoconstrictor neurons.   Because the majority of NPY-negative large 
postganglionic neurons are involved in the secretomotor pathway (Gibbins, 1995), and 
postganglionic neurons which are encircled by GABA-positive baskets exit the SCG through the 
internal carotid nerve (Wolff et al., 1989), postganglionic neurons encircled by GABA-positive 
preganglionic fibers may regulate the activity of glands located in the cranium.
Since the resting membrane potential is −45~−90 mV (Adams and Harper, 1995) and the 
reversal potential for chloride ion is −40~−50 mV in the SCG neurons (Sacchi et al., 1999), GABA 
may depolarize these neurons. On the other hand, because the threshold for action potential 
production is 12.2 mV in the SCG neurons (Adams and Harper, 1995), activation of GABAA
receptors may inhibit action potential production in postganglionic neurons.  It seems strange that 
fibers from a single SPN co-release neurotransmitters which have opposite effects on action
potential production.
Nevertheless, the co-expression of excitatory and inhibitory neurotransmitters has been 
reported in other regions of the brain such as granule cells in the hippocampus (Gutierrez, 2003), 
interneurons in the neocortex (Hioki et al., 2004), and immature lateral superior olivary neurons 
(Gillespie et al., 2005), although the function remained unclear.
It has also been reported that GABA strongly inhibits long-term potentiation via GABAA
receptors in the rat SCG (Guillermo et al., 1994). As noted above, GABAergic preganglionic 
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fibers preferentially innervate NPY-negative secretomotor neurons, and associate with only a small
number of NPY-positive postganglionic neurons.  Therefore, postganglionic neurons innervated by 
GABAergic fibers, which may be associated with secretomotor functions, may be inhibited from 
producing long-term potentiation.
However, there is no direct evidence of targets which receive sympathetic postganglionic
innervation related to the spinal preganglionic GABAergic input, or that the LTP blockade 
phenomenon caused by stimulating GABAergic fibers exists. There also arises the question of
whether the chloride equilibrium potential for cells surrounded by GABAergic baskets differs from 
that those for the other postganglionic neurons or not. The identification of postganglionic 
neurons richly innervated by GABAergic fibers, and morphological, electrophysiological, and 
pharmacological studies of these neurons are needed.
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Figure legends: 
Figure 1 (monochrome) 
Immunostaining for GABA and GAD67 in the SCG and STG.  Many GABA-immunopositive 
varicose fibers (a) and a few small GABA-immunopositive cells (arrows in b, c) were observed in 
the ganglia after staining with the TSA method. These GABA-immunopositive cells were often in
close proximity to GABA-immunopositive varicose fibers (arrowheads in b, c). No 
immunoreactivity was observed when sections were incubated with anti-GABA antibody 
preabsorbed with GABA (d). GAD67-immunoreactive varicose fibers were observed frequently in 
the SCG (e1) and less frequently in the STG (f1), and often made basket-like structures (inset in e1), 
but no immunoreactive cell body was found in the ganglia even when the sections were incubated 
in the primary antibody solution without Triton X-100 and processed with the sensitive TSA method 
(g).  No immunoreactivity was observed in the ganglia (e2, f2) or brain (h2) when the sections were 
incubated with anti-GAD67 antibody preabsorbed with GAD67-GST fusion protein. Scale bars: 
25 µm in a, d-g, 10 µm in b, c, and 2 mm in h. 
Figure 2 (monochrome) 
GAD-expression in the SCG and STG.  No cell body which expresses GAD65 mRNA was found 
in the SCG (a) or STG (b). Nor was found GAD67 mRNA expression in the SCG (c) and STG (d). 
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Brain sections reacted with GAD65 (e1) and GAD67 (f1) antisense riboprobes showed strong 
signals in many regions as reported previously.  No signal was observed in the brain sections 
reacted with the sense probe for GAD65 (e2) or GAD67 (f2). Note: the olfactory bulb and inferior 
colliculus are not included in the section of e1. Scale bars: 50 µm in a-d, and 2 mm in e, f. 
Figure 3 (monochrome) 
GAD-expression in the thoracic spinal cord and DRGs. Many neurons expressed mRNAs for 
GAD65 (a1) and GAD67 (b1) in the gray matter of thethoracic spinal cord, including the 
intermediolateral nucleus (IML) and region around the central canal (cc). On the other hand, no 
GAD65 (c) or GAD67 (d) mRNA-expressing cell was found in the DRGs of C8-T5 spinal segments. 
Moreover, no cell body or fiber immunopositive for GABA was observed in the DRGs (e) or DRs 
(f) of C8-T5 spinal segments.  Nor was observed GAD67 immunoreactivity in the DRGs (h) and 
DRs (i). In contrast, GABA- (g) and GAD67- (arrows in j) immunopositive fibers were observed 
in the VRs. No staining was observed when the sections were reacted with the sense riboprobe (a2, 
b2). In the immunohistochemistry, sections were incubated in the primary antibody solution without 
Triton X-100. In the immunohistochemistry for GABA (e, g), the TSA method was used for signal 
enhancement. Scale bars: 50 µm in a, b, e, f, h, i, 400 µm in c, d, and 20 µm in g, j.  
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Figure 4 (color figure) 
Origin and chemistry of GAD67-immunopositive fibers in the sympathetic ganglia.  Almost all 
GAD67-immunopositive varicosities in the SCG and STG exhibited VAchT immunoreactivity 
(single arrowheads in a-c), although many varicosities showed VAchT immunoreactivity alone 
(double arrowheads in a-c).  After the injection of recombinant Sindbis/palGFP virus into the T1 
IML, many neurons around the injection site in the longitudinal section of the spinal cord showed 
GFP-immunoreactivity (dark brown structures in d), and some of them were located in the IML 
(box in d; e). In the SCG, some anterogradely labeled fibers (f) showed GAD67 immunoreactivity 
(arrowheads in g-g’’). Note: The section was counterstained with neutral red in d and e.  LF, 
lateral funiculus; PF, posterior funiculus. Scale bars: 10 µm in a, c, g, 5 µm in b, 300 µm in d, 50
µm in e, and 20 µm in f. 
Figure 5 (color figure) 
GABA-producing SPNs in the thoracic spinal cord. In sections stained with fluorescent dyes (a; 
FG immunoreactivity is represented by green in a, and GAD67 mRNA signal is represented by 
magenta in a’’), some retrogradely labeled SPNs showed signal for GAD67 mRNA (arrows in a-a’’) 
after the injection of FG into the right SCG.  Combined immunoperoxidase staining for FG 
(visualized with DAB; brown structures in b) and alkaline phosphatase in situ hybridization for 
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GAD67 mRNA (visualized with nitroblue tetrazolium; dark blue structures in b) were performed to 
investigate the morphology of GAD67-expressing SPNs (b). The camera lucida reconstruction
showed that the GAD67-expressing SPNs (cells A-6, B-4, B-11, B-14, B-18, and C-10 cells in c) 
were not distinguishable from GAD67-negative SPNs (cells A-N1, B-N1, B-N2, and C-N1 cells in 
c). As seen in the superimposed drawing of the longitudinal sections of C8-T5 spinal cord (d), a 
majority of GAD67-expressing SPNs were located in the rostral part of the IML, and a histogram of 
GAD67-expressing SPNs along the rostro-caudal axis (e) clearly displayed that the numbers of 
these neurons were significantly larger in the most rostral part (bar 0-2.3mm in e) than any other 
part of the IML (Tukey’s multiple analysis, p<0.05). In a histogram of GAD67-expressing SPNs 
along the relative distance from the midline of the spinal cord (f) (zero indicates that a neuron is 
located at the midline, and 1 indicates that a neuron is located in the most lateral part of the IML at 
the single rostro-caudal level), GAD67-expressing SPNs tended to be located in the central (0-0.2)
and lateral (0.6-0.8) part of the gray matter, although no significance was detected (ANOVA, 
p=0.073). Scale bars: 20 µm in a, b, 50 µm in c, and 1 mm in d.
Figure 6 (monochrome) 
Effect of nerve transection of C8-T4 VRs on GAD67 and GABA immunoreactivities in the 
sympathetic ganglia. After the transection of C8-T4 VRs, almost all GAD67-immunopositive 
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fibers and varicosities disappeared from the ipsilateral SCG (a) and STG (c), whereas positive fibers 
were preserved in the contralateral SCG (b) and STG (d). GABA-positive fibers also disappeared 
from the ipsilateral sympathetic ganglia (e).  Furthermore, no SIF-like cells showed GABA 
immunoreactivity, although GABA-positive SIF-like cells were observed in the contralateral 
ganglia (inset in f).  Scale bars: 100 µm (a-f), 10 µm in inset in f.  
Table 1. Details of Antibodies Used for Immunohistochemistry
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Figure 1 (monochrome) Immunostaining for GABA and GAD67 in the SCG and STG. Many 
GABA-immunopositive varicose fibers (a) and a few small GABA-immunopositive cells 
(arrows in b, c) were observed in the ganglia after staining with the TSA method. These 
GABA-immunopositive cells were often in close proximity to GABA-immunopositive 
varicose fibers (arrowheads in b, c). No immunoreactivity was observed when sections 
were incubated with anti-GABA antibody preabsorbed with GABA (d). GAD67-
immunoreactive varicose fibers were observed frequently in the SCG (e1) and less 
frequently in the STG (f1), and often made basket-like structures (inset in e1), but no 
immunoreactive cell body was found in the ganglia even when the sections were 
incubated in the primary antibody solution without Triton X-100 and processed with the 
sensitive TSA method (g). No immunoreactivity was observed in the ganglia (e2, f2) or 
brain (h2) when the sections were incubated with anti-GAD67 antibody preabsorbed with 
GAD67-GST fusion protein. Scale bars: 25 m in a, d-g, 10 m in b, c, and 2 mm in h. 
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Figure 2 (monochrome) GAD-expression in the SCG and STG. No cell body which 
expresses GAD65 mRNA was found in the SCG (a) or STG (b). Nor was found GAD67 
mRNA expression in the SCG (c) and STG (d). Brain sections reacted with GAD65 (e1) and 
GAD67 (f1) antisense riboprobes showed strong signals in many regions as reported 
previously. No signal was observed in the brain sections reacted with the sense probe for 
GAD65 (e2) or GAD67 (f2). Note: the olfactory bulb and inferior colliculus are not 
included in the section of e1. Scale bars: 50 m in a-d, and 2 mm in e, f.  
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Figure 3 (monochrome) GAD-expression in the thoracic spinal cord and DRGs. Many 
neurons expressed mRNAs for GAD65 (a1) and GAD67 (b1) in the gray matter of 
thethoracic spinal cord, including the intermediolateral nucleus (IML) and region around 
the central canal (cc). On the other hand, no GAD65 (c) or GAD67 (d) mRNA-expressing 
cell was found in the DRGs of C8-T5 spinal segments. Moreover, no cell body or fiber 
immunopositive for GABA was observed in the DRGs (e) or DRs (f) of C8-T5 spinal 
segments. Nor was observed GAD67 immunoreactivity in the DRGs (h) and DRs (i). In 
contrast, GABA- (g) and GAD67- (arrows in j) immunopositive fibers were observed in the 
VRs. No staining was observed when the sections were reacted with the sense riboprobe 
(a2, b2). In the immunohistochemistry, sections were incubated in the primary antibody 
solution without Triton X-100. In the immunohistochemistry for GABA (e, g), the TSA 
method was used for signal enhancement. Scale bars: 50 m in a, b, e, f, h, i, 400 m in 
c, d, and 20 m in g, j.  
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Figure 4 (color figure) Origin and chemistry of GAD67-immunopositive fibers in the 
sympathetic ganglia. Almost all GAD67-immunopositive varicosities in the SCG and STG 
exhibited VAchT immunoreactivity (single arrowheads in a-c), although many varicosities 
showed VAchT immunoreactivity alone (double arrowheads in a-c). After the injection of 
recombinant Sindbis/palGFP virus into the T1 IML, many neurons around the injection 
site in the longitudinal section of the spinal cord showed GFP-immunoreactivity (dark 
brown structures in d), and some of them were located in the IML (box in d; e). In the 
SCG, some anterogradely labeled fibers (f) showed GAD67 immunoreactivity (arrowheads 
in g-gff). Note: The section was counterstained with neutral red in d and e. LF, lateral 
funiculus; PF, posterior funiculus. Scale bars: 10 m in a, c, g, 5 m in b, 300 m in d, 
50 m in e, and 20 m in f.  
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Figure 5 (color figure) GABA-producing SPNs in the thoracic spinal cord. In sections 
stained with fluorescent dyes (a; FG immunoreactivity is represented by green in a, and 
GAD67 mRNA signal is represented by magenta in aff), some retrogradely labeled 
SPNs showed signal for GAD67 mRNA (arrows in a-aff) after the injection of FG into 
the right SCG. Combined immunoperoxidase staining for FG (visualized with DAB; brown 
structures in b) and alkaline phosphatase in situ hybridization for GAD67 mRNA 
(visualized with nitroblue tetrazolium; dark blue structures in b) were performed to 
investigate the morphology of GAD67-expressing SPNs (b). The camera lucida 
reconstruction showed that the GAD67-expressing SPNs (cells A-6, B-4, B-11, B-14, B-18, 
and C-10 cells in c) were not distinguishable from GAD67-negative SPNs (cells A-N1, B-
N1, B-N2, and C-N1 cells in c). As seen in the superimposed drawing of the longitudinal 
sections of C8-T5 spinal cord (d), a majority of GAD67-expressing SPNs were located in 
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the rostral part of the IML, and a histogram of GAD67-expressing SPNs along the rostro-
caudal axis (e) clearly displayed that the numbers of these neurons were significantly 
larger in the most rostral part (bar 0-2.3mm in e) than any other part of the IML 
(Tukeyfs multiple analysis, p<0.05). In a histogram of GAD67-expressing SPNs along 
the relative distance from the midline of the spinal cord (f) (zero indicates that a neuron 
is located at the midline, and 1 indicates that a neuron is located in the most lateral part 
of the IML at the single rostro-caudal level), GAD67-expressing SPNs tended to be located 
in the central (0-0.2) and lateral (0.6-0.8) part of the gray matter, although no 
significance was detected (ANOVA, p=0.073). Scale bars: 20 m in a, b, 50 m in c, and 
1 mm in d.  
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immunoreactivities in the sympathetic ganglia. After the transection of C8-T4 VRs, almost 
all GAD67-immunopositive fibers and varicosities disappeared from the ipsilateral SCG (a) 
and STG (c), whereas positive fibers were preserved in the contralateral SCG (b) and STG 
(d). GABA-positive fibers also disappeared from the ipsilateral sympathetic ganglia (e). 
Furthermore, no SIF-like cells showed GABA immunoreactivity, although GABA-positive 
SIF-like cells were observed in the contralateral ganglia (inset in f). Scale bars: 100 m
(a-f), 10 m in inset in f.  
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Table 1. Details of Antibodies Used for Immunohistochemistry
Antibody Host
Mono or 
polyclonal
Source
Catalog 
no.
Lot no. Antigen Specificity 
Anti-vesicular 
acetylcholine 
transporter 
(VAchT)
Goat Poly Chemicon AB1578 18112610
Synthetic peptide corresponding 
to C-terminus of cloned rat 
VAchT 
(CSPPGPFDGCEDDYNYYSRS; 
suplied by Chemicon on request)
Absorbed with control peptide (AG260, Chemicon); single band around 
65-70kDa on immunoblot 
(http://www.chemicon.com/browse/productdetail.asp?ProductID=ab1578).
Anti-gamma 
aminobutyric 
acid (GABA)
Rabbit Poly Sigma-Aldrich A2052 101K4837
GABA conjugated with bovine 
serum albumin (GABA-BSA)
Absorbed with GABA; only GABA-BSA, but not glycine-BSA, was 
detected on dot blot (Ligorio et al.,2000).
Anti-glutamic 
acid 
decarboxylase 
of 67kDa 
(GAD67)
Mouse Mono Chemicon MAB5406 25080061 Recombinant GAD67 protein
Absorbed with GST-GAD67 fusion protein; single band around 67kDa on 
the immunoblot (Fong et al., 2005); immunoreactivity was in very good 
agreement with a previous study (Mugnaini and Oeltel, 1985).
Anti-fluorogold Rabbit Poly Chemicon AB153 0509010863 Fluorogold
Lack of immunoreactivity in the sections of animals which were not 
injected with fluorogold.
Anti-enhanced 
green 
fluorescent 
protein (GFP)
Rabbit Poly
Prof. T. 
Kaneko 
(Kyoto Univ)
N/A N/A Recombinant GFP protein
Lack of immunoreactivity in the sections of animals which do not express 
GFP; affinity purified (Tamamaki et al., 2000).
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